Effects of screening for breast cancer on its age-incidence relationships and familial risk

被引:22
作者
Hemminki, K
Bermejo, JL
机构
[1] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
[2] Karolinska Inst, Dept Biosci Novum, Huddinge, Sweden
关键词
breast cancer; mammographic screening; age-incidence; familial risk;
D O I
10.1002/ijc.21149
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mammographic screening programs for breast cancer have been implemented in many countries and opportunistic mammographies are taken as a diagnostic method. The consequences of the wide application of this technology to age-incidence relationships in breast cancer have not been clarified nor is its effect on familial risk estimation. It was assumed that if screening and diagnostic methods bias familial risk, the highest risk should be noted for sisters diagnosed close in time. Age-specific incidence data were collected from the EUCAN database and from cancer registries of Finland, Norway and Sweden. The Swedish Family-Cancer Database was used to analyse risks for breast cancer among sisters, depending on the time since the first sister was diagnosed with breast cancer. Age-incidence patterns deviated between Germany, with low mammographic coverage, and Sweden, the Netherlands, the UK and France, with variable levels of coverage. The annual age-incidence patterns in Finland, Norway and Sweden changed in concert with the targeted mammographic service. The risk of breast cancer for women with an affected sister, diagnosed between ages 50 to 64 years, was significantly higher within the same or the subsequent year of the sister's diagnosis compared to 5+ years, accounting for 7.3% of all patients. The ordered increase in age-specific incidence of breast cancer in the women targeted by screening studied suggests that mammographic screening is one important factor responsible for the shift of the age of onset for breast cancer towards middle age. However, the effects on the estimation of familial risk are so far small. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 20 条
[1]  
Anttila A, 1999, INT J CANCER, V83, P59, DOI 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO
[2]  
2-N
[3]   Evidence from randomised trials on the long-term effects of hormone replacement therapy [J].
Beral, V ;
Banks, E ;
Reeves, G .
LANCET, 2002, 360 (9337) :942-944
[4]   A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations [J].
Bermejo, JL ;
Hemminki, K .
ANNALS OF ONCOLOGY, 2005, 16 (02) :322-329
[5]   American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility [J].
Bruinooge, SS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2397-2406
[6]   The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation [J].
Duffy, SW ;
Tabar, L ;
Vitak, B ;
Yen, MF ;
Warwick, J ;
Smith, RA ;
Chen, HH .
ANNALS OF ONCOLOGY, 2003, 14 (08) :1196-1198
[7]   Prostate cancer screening, changing age-specific incidence trends and implications on familial risk [J].
Hemminki, K ;
Rawal, R ;
Bermejo, JL .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (02) :312-315
[8]   Mammographic screening is dramatically changing age-incidence data for breast cancer [J].
Hemminki, K ;
Rawal, R ;
Bermejo, JL .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) :4652-4653
[9]  
Hemminki K, 2001, ACTA ONCOL, V40, P772
[10]   Sibling risks in cancer: clues to recessive or X-linked genes? [J].
Hemminki, K ;
Vaittinen, P ;
Dong, C ;
Easton, D .
BRITISH JOURNAL OF CANCER, 2001, 84 (03) :388-391